Back to Results
First PageMeta Content
Canakinumab / Novartis / IL1B / Medicine / Immune system / Organofluorides / Monoclonal antibodies / Anakinra / Flucytosine / Immunosuppressants / Cytokines / Pharmacology


HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ILARIS safely and effectively. See full prescribing information for ILARIS. ILARIS (canakinumab) injection for subcu
Add to Reading List

Document Date: 2014-10-17 09:51:37


Open Document

File Size: 559,50 KB

Share Result on Facebook

City

Reference / /

Company

AEs / ITT / SUSPECTED ADVERSE REACTIONS / Alteon Inc. / Novartis Pharmaceuticals Corporation / /

Currency

pence / /

Event

Product Recall / Product Issues / FDA Phase / /

Facility

Laboratory Findings Hematology During / Laboratory Findings DRUG INTERACTIONS / /

IndustryTerm

clear solution / rubber stopper / medicinal products / otitis media / medicinal product / Healthcare providers / mg/mL solution / /

MedicalCondition

scar / viral infection / headache / herpes zoster / urticaria-like rash / measles / urinary tract infection / potential infection / Active Systemic Juvenile Idiopathic Arthritis / nausea / frequently reported infection / Serious Infections / rhinitis / Vertigo Vertigo / intra-abdominal abscess / conjunctivitis / CAPS disorders / fatigue / chronic inflammation / disease activity / Macrophage Activation Syndrome Macrophage activation syndrome / disorder / aspergillosis / latent tuberculosis infections / active and latent tuberculosis infection / anaphylactic reactions / Hypersensitivity / diarrhea / Neonatal Onset Multisystem Inflammatory Disorder / sinusitis / severe autoinflammatory disease / otitis media / observed infections / inactivated influenza / Familial Cold Autoinflammatory Syndrome / infections / influenza / clinical hypersensitivity / Cryopyrin-Associated Periodic Syndromes / respiratory tract infection / sepsis / positive tuberculosis / atypical mycobacterial infections / abdominal pain / lymph node abscess / infestations All Infections / Muckle-Wells Syndrome / pneumonia / latent tuberculosis infection / minimal disease / opportunistic infections / disease / arthralgia / nasopharyngitis / gastroenteritis / Carcinogenesis / neutropenia / vertigo / fever / skin disease / persistent cough / latent tuberculosis / tumor necrosis factor / Confirmed hypersensitivity / systemic amyloidosis / infection / inflammatory disease / tonsillitis / Serious Infections ILARIS / Systemic Juvenile Idiopathic Arthritis / inflammation / CONTRAINDICATIONS Confirmed hypersensitivity / varicella / L. A disease / Hypersensitivity Hypersensitivity / pharyngitis / serious infection / disorders / tuberculosis / upper respiratory tract infections / /

MedicalTreatment

Immunization / appendectomy / immunization schedules / Immunizations / vaccination / intravenous infusion / Immunosuppression / vaccinations / /

Organization

Administration of ILARIS / DOSAGE AND ADMINISTRATION / FDA / /

/

Position

physician / General / representative / reporter / /

Product

delivery / Sterile Water for Injection / IL-1 / No injection / no / ILARIS / CAPS Patients Preferred / /

Technology

antibodies / Pharmacokinetics / Pharmacodynamics / /

URL

http /

SocialTag